论文信息 - Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial. - 字舞流文

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial.

C. Tibaldi | L. Crinò | A. Ardizzoni | L. Boni | M. Tiseo | C. Dazzi | R. Passalacqua | E. Baldini | E. Defraia | S. Cinieri | M. G. Vitale | N. Zilembo | F. Riccardi | F. Zanelli | V. D’alessandro | A. Camerini | F. Ambrosio | G. M. Turolla